Cargando…

Triple combination therapy for pancreatic cancer remodels stroma and improves survival

Detalles Bibliográficos
Autores principales:	Vázquez-Arreguín, Karina, Kaur, Balveen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2023
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041460/ https://www.ncbi.nlm.nih.gov/pubmed/36992913 http://dx.doi.org/10.1016/j.omto.2023.03.001

Ejemplares similares

The role of artificial intelligence to quantify the tumour-stroma ratio for survival in colorectal cancer
por: Smit, Marloes A, et al.
Publicado: (2020)

Remodeling of Tumor Stroma and Response to Therapy
por: Johansson, Anna, et al.
Publicado: (2012)

Adenosine in pancreatic cancer: Emerging combination therapies
por: Roth, Susanne, et al.
Publicado: (2019)

New highlights on stroma–epithelial interactions in breast cancer
por: Barcellos-Hoff, Mary Helen, et al.
Publicado: (2005)

Milking the stroma in triple-negative breast cancer
por: Thompson, Alastair M., et al.
Publicado: (2012)

Cancer Associated Fibroblasts: The Architects of Stroma Remodeling
por: Santi, Alice, et al.
Publicado: (2018)

Revisiting stroma in pancreatic cancer
por: Khan, Sheema, et al.
Publicado: (2015)

T cells in pancreatic cancer stroma
por: Goulart, Michelle R, et al.
Publicado: (2021)

Pancreatic cancer, stroma, and exosomes
por: Closa, Daniel
Publicado: (2022)

The role of the myofibroblast in tumor stroma remodeling
por: Otranto, Marcela, et al.
Publicado: (2012)

Combating CHK1 resistance in triple negative breast cancer: EGFR inhibition as potential combinational therapy
por: Stefanski, Casey D., et al.
Publicado: (2022)

B cells in pancreatic cancer stroma
por: Delvecchio, Francesca Romana, et al.
Publicado: (2022)

Targeting the Stroma in the Management of Pancreatic Cancer
por: Edwards, Penelope, et al.
Publicado: (2021)

Can the stroma provide the clue to the cellular basis for mammographic density?
por: Warren, Ruth, et al.
Publicado: (2003)

Stroma-Targeting Therapy in Pancreatic Cancer: One Coin With Two Sides?
por: Jiang, Bolun, et al.
Publicado: (2020)

RNA nanoparticles for targeted therapies of triple-negative breast cancers
por: Danai, Leyla, et al.
Publicado: (2023)

Cancer-associated fibroblasts mediate cancer progression and remodel the tumouroid stroma
por: Pape, Judith, et al.
Publicado: (2020)

Soluble stroma‐related biomarkers of pancreatic cancer
por: Resovi, Andrea, et al.
Publicado: (2018)

Natural killer cells in pancreatic cancer stroma
por: Fincham, Rachel Elizabeth Ann, et al.
Publicado: (2021)

Differential Contribution of Pancreatic Fibroblast Subsets to the Pancreatic Cancer Stroma
por: Garcia, Paloma E., et al.
Publicado: (2020)

Deploying triple artemisinin-based combination therapy (TACT) for malaria treatment in Africa: ethical and practical considerations
por: Tindana, Paulina, et al.
Publicado: (2021)

Triple combinations of immunotherapy and targeted therapy in patients with melanoma with brain metastases
por: Rutkowski, Piotr, et al.
Publicado: (2023)

Bioinspired lipoproteins-mediated photothermia remodels tumor stroma to improve cancer cell accessibility of second nanoparticles
por: Tan, Tao, et al.
Publicado: (2019)

Being the Alice of academia: lessons from the Red Queen hypothesis
por: Negatu, S G, et al.
Publicado: (2022)

Triple-Negative Breast Cancer: A Review of Current Curative Intent Therapies
por: MacDonald, Isaiah, et al.
Publicado: (2022)

Tumour Stroma Ratio Assessment Using Digital Image Analysis Predicts Survival in Triple Negative and Luminal Breast Cancer
por: Millar, Ewan KA, et al.
Publicado: (2020)

Pancreatic Cancer: Targeted Therapy Holds the Promise
por: Zhou, Zhijun, et al.
Publicado: (2021)

Artificial intelligence and improved early detection for pancreatic cancer
por: Zhong, Jun, et al.
Publicado: (2023)

Pancreatic Alpha Cells Hold the Key to Survival
por: Wali, Jibran A., et al.
Publicado: (2015)

Targeting the tumor stroma for cancer therapy
por: Xu, Maosen, et al.
Publicado: (2022)

Providing meaningful survival benefit to hepatocellular carcinoma patients: combination therapy of future
por: Sarkar, Devanand
Publicado: (2022)

A PARP inhibitor in pancreatic cancer: Enhancement anti-tumour activity of chemoradiation therapy against pancreatic cancer?
por: Furuse, Junji
Publicado: (2019)

Clinical Interpretation of Efficacy Outcomes in Pharmacological Studies on Triple Fixed-Dose Combination Therapy for Uncontrolled Asthma: Assessment of IRIDIUM and ARGON Studies
por: Rogliani, Paola, et al.
Publicado: (2022)

Silencing PCBP2 normalizes desmoplastic stroma and improves the antitumor activity of chemotherapy in pancreatic cancer
por: Li, Yuanke, et al.
Publicado: (2021)

Emerging concepts in pancreatic cancer medicine: targeting the tumor stroma
por: Neesse, Albrecht, et al.
Publicado: (2013)

Pathophysiological role of microRNA-29 in pancreatic cancer stroma
por: Kwon, Jason J., et al.
Publicado: (2015)

Role of Tumor and Stroma-Derived IGF/IGFBPs in Pancreatic Cancer
por: Thomas, Divya, et al.
Publicado: (2020)

Adipose-enriched peri-tumoral stroma, in contrast to myofibroblast-enriched stroma, prognosticates poorer survival in breast cancers
por: Lau, Hannah Si Hui, et al.
Publicado: (2023)

Novel 3D µtissues Mimicking the Fibrotic Stroma in Pancreatic Cancer to Study Cellular Interactions and Stroma-Modulating Therapeutics
por: Pednekar, Kunal P., et al.
Publicado: (2021)

The role of triple therapy and therapy sequence in treatment of BRAF-mutant metastatic melanoma. Response to overall survival with first-line atezolizumab in combination with vemurafenib and cobimetinib in BRAFV600 mutation-positive advanced melanoma (IMspire150): second interim analysis of a multicentre, randomised, phase 3 study
por: Dummer, Reinhard, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1kdcmf8khb5fosjrt6cocjhv60